TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Merck Life Science AS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
186,464
|
209,101
|
171,945 |
Financial expenses |
446
|
574
|
58 |
Earnings before taxes |
11,250
|
19,974
|
12,438 |
Total assets |
98,433
|
102,839
|
76,366 |
Current assets |
98,385
|
102,440
|
75,783 |
Current liabilities |
22,016
|
30,352
|
21,129 |
Equity capital |
76,417
|
72,488
|
55,238 |
- share capital |
12,339
|
13,215
|
12,818 |
Employees (average) |
12
|
9 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
77.6%
|
70.5%
|
72.3% |
Turnover per employee |
17,425
|
19,105 | |
Profit as a percentage of turnover |
6.0%
|
9.6%
|
7.2% |
Return on assets (ROA) |
11.9%
|
20.0%
|
16.4% |
Current ratio |
446.9%
|
337.5%
|
358.7% |
Return on equity (ROE) |
14.7%
|
27.6%
|
22.5% |
Change turnover |
-8,783
|
31,827
|
25,545 |
Change turnover % |
-4%
|
18%
|
17% |
Chg. No. of employees |
3
|
-1 | |
Chg. No. of employees % |
33%
|
-10% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.